-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Xylem, Lowers Price Target to $135

Benzinga·10/28/2026 12:44:48
Listen to the news
Oppenheimer analyst Bryan Blair maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $150 to $135.